AJP - Renal Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Renal Physiol 291: F761-F769, 2006. First published April 4, 2006; doi:10.1152/ajprenal.00326.2005
0363-6127/06 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/4/F761    most recent
00326.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pittner, J.
Right arrow Articles by Pallone, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pittner, J.
Right arrow Articles by Pallone, T. L.

Ouabain modulation of endothelial calcium signaling in descending vasa recta

János Pittner,1 Kristie Rhinehart,1 and Thomas L. Pallone1,2

1Division of Nephrology, Department of Medicine, and 2Department of Physiology, University of Maryland School of Medicine, Baltimore, Maryland

Submitted 12 August 2005 ; accepted in final form 27 March 2006


   ABSTRACT
TOP
 ABSTRACT
METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Using fura 2-loaded vessels, we tested whether ouabain modulates endothelial cytoplasmic calcium concentration ([Ca2+]CYT) in rat descending vasa recta (DVR). Over a broad range between 10–10 and 10–4 M, ouabain elicited biphasic peak and plateau [Ca2+]CYT elevations. Blockade of voltage-gated Ca2+ entry with nifedipine did not affect the response to ouabain mitigating against a role for myo-endothelial gap junctions. Reduction of extracellular Na+ concentration ([Na+]o) or Na+/Ca2+ exchanger (NCX) inhibition with SEA-0400 (10–6 M) elevated [Ca2+]CYT, supporting a role for NCX in the setting of basal [Ca2+]CYT. SEA-0400 abolished the [Ca2+]CYT response to ouabain implicating NCX as a mediator. The transient peak phase of [Ca2+]CYT elevation that followed either ouabain or reduction of [Na+]o was abolished by 2-aminoethoxydiphenyl borate (5 x 10–5 M). Cation channel blockade with La3+ (10 µM) or SKF-96365 (10 µM) also attenuated the ouabain-induced [Ca2+]CYT response. Ouabain pretreatment increased the [Ca2+]CYT elevation elicited by bradykinin (10–7 M). We conclude that inhibition of ouabain-sensitive Na+-K+-ATPase enhances DVR endothelial Ca2+ store loading and modulates [Ca2+]CYT signaling through mechanisms that involve NCX, Ca2+ release, and cation channel activation.

kidney; medulla; fura 2; SEA-0400; bradykinin; 2-aminoethoxydiphenyl borate

OUABAIN IS A CARDIOTONIC STEROID that inhibits plasmalemmal Na+-K+-ATPase by binding to its {alpha}-subunit. Ouabain, or a closely related analog [ouabain-like factor (OLF)], is endogenously produced by the adrenal glands and circulates systemically in low concentrations (8, 19, 21). The binding site for ouabain, the "ouabain receptor," is highly conserved in evolution implying an important functional role for OLF. The role of ouabain has been debated for decades. A hypothesis is that inhibition of Na+ export from the cell by ouabain raises subplasmalemmal Na+ concentration, secondarily inhibiting Ca2+ export by Na+/Ca2+ exchange (NCX). One important effect of the decrease in Ca2+ export may be to augment loading of Ca2+ into endoplasmic/sarcoplasmic reticulum (ER/SR) stores. Through that putative mechanism, ouabain has been shown to augment agonist-induced cytoplasmic Ca2+ concentration ([Ca2+]CYT) transients and intensify vasoconstriction (2). In addition to such effects, mediated through NCX inhibition, elegant experiments by Xie and colleagues (50, 51) have shown that ouabain binding to Na+ pumps leads to downstream signaling events that may include activation of phospholipase C (PLC) and inositol tris-phosphate (InsP3) generation. In contrast to effects on smooth muscle and cardiac myocytes, the role of ouabain to modulate microvascular endothelial [Ca2+]CYT has not been as thoroughly explored.

Descending vasa recta (DVR) are 15-µm-diameter branches of juxtamedullary efferent arterioles that carry blood flow to the renal medulla. They are lined by a continuous endothelium and surrounded by smooth muscle pericytes that impart contractile function (36, 38). Agonists such as acetylcholine and bradykinin (BK) elevate endothelial [Ca2+]CYT to release vasodilators and limit DVR vasoconstriction (12, 37, 38, 43). Freshly isolated DVR are an attractive model to study endothelial [Ca2+]CYT responses in an intact microvessel preparation because the Ca2+-sensitive fluorophore fura-2 loads preferentially into the endothelium, sparing the pericytes (37). In this study, we exploited that feature to test the hypothesis that, as in smooth muscle and neurons, ouabain modulates DVR endothelial [Ca2+]CYT. Our results verify that ouabain, over a broad range of concentrations, increases basal [Ca2+]CYT in a biphasic manner. Na+/Ca2+ exchanger (NCX) and other pathways participate in the response. NCX blockade with SEA-0400, inositol trisphosphate receptor (InsP3R) blockade with 2-aminoethoxydiphenyl borate (2-APB), and nonselective cation channel blockade with La3+ or SKF-96365 interfere with the actions of ouabain. Finally, prolonged ouabain pretreatment increased the magnitude of [Ca2+]CYT elevation induced by BK suggesting enhancement of store loading of Ca2+ in DVR endothelium. These results imply that OLF may operate through complex signaling pathways to modulate vasoactivity in the renal medulla.


   METHODS
TOP
 ABSTRACT
 METHODS
RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Isolation of DVR. Investigations involving animal use described herein were performed according to protocols approved by the Institutional Animal Care and Use Committee of the University of Maryland. Kidneys were harvested from Sprague-Dawley rats (70–150 g; Harlan Sprague Dawley, Indianapolis, IN). Before nephrectomy, the rats were deeply anesthetized with ketamine (80 mg/kg) and xylazine (10 mg/kg) by intraperitoneal injection. Kidney slices were placed in dissection buffer and maintained at 4°C. The buffer used for dissection and superfusion of DVR contained (in mM) 140 NaCl, 10 Na-acetate, 5 KCl, 1.2 MgSO4, 1.2 Na2HPO4, 5 HEPES, 5 D-glucose, 5 L-alanine, 0.1 L-arginine, and 1 CaCl2. The pH was adjusted to 7.55 at room temperature to yield a pH of ~7.4 at 37°C. Horizontal kidney slices were digested for 15–18 min in DMEM media containing Liberase Blendzyme 1 (Roche Boehringer Mannheim, 0.56 U Collagenase + Dispase in 0.7 ml DMEM) at 37°C. Individual DVR were dissected from the outer medulla and transferred to a heated chamber fitted to the stage of a Nikon Diaphot inverted microscope. The vessels were immobilized on glass pipettes.

Measurement of endothelial [Ca2+]CYT. DVR were loaded with fura 2-AM (5 µM) added to the bath at 37°C for 15 min. We previously showed that fura 2 preferentially loads into the endothelial cells, yielding little fluorescent signal from pericytes (37). The vessels were visualized with a Nikon Fluor x40 (numerical aperture 1.3) oil immersion objective. For measurement of [Ca2+]CYT with fura 2, vessels were excited at 350 and 380 nm. Excitation frequencies were selected with a computer-controlled monochromator (PTI). A photon-counting photomultiplier assembly was fitted to the microscope and used to detect fluorescent emission from the probe. Fluorescent emissions were isolated using a 510WB40 (Omega optical) filter. Background-subtracted fluorescence emission ratios (R350/380) were converted to [Ca2+]CYT assuming a dissociation constant for fura 2 of 224 nM. Rmin and Rmax were measured in vessels exposed to 10–5 M ionomycin with 0 CaCl2 and 5 x 10–4 M EGTA, or 5 x 10–3 M CaCl2, respectively (37).

Membrane potential measurement. To obtain electrical access for membrane potential recording, we used perforated patches formed on endothelia. The abluminal surface of DVR endothelia was exposed by collagenase treatment and removal of pericytes. The electrode solution was (in mmol/l): 120 kaspartate, 20 KCl, 10 NaCl, 10 HEPES, pH 7.2 and nystatin (100 µg/ml, 0.1% DMSO). The extracellular solution was physiological saline (PSS; in mmol/l): 155 NaCl, 5 KCl, 1 MgCl2, 1 CaCl2, 10 HEPES, and 10 glucose, pH 7.4. Membrane potential recordings were performed in current clamp mode (I = 0) at a sampling rate of 10 Hz. The methods for endothelial exposure, patch-clamp recording, and junction potential correction have been extensively described (42).

Reagents. Stock solutions of SEA-0400 (2-{4-[(2,5-difluorophenyl) methoxy]phenoxy}-5-ethoxyaniline; Calbiochem, 10–4 M), nifedipine (Sigma, 10–2 M), and 2-APB (Calbiochem, 10–2 M) were prepared in DMSO. SKF-96365 (1-{beta-[3-(4-methoxyphenyl)propoxy]-4-methoxyphenethyl}-1H-imidazole hydrochloride, 10–2 M) and BK (Sigma, 10–4 M) were dissolved in water and stored at –20°C. Ouabain (Sigma) was dissolved in dissection buffer at 10–4 M and stored at –20°C. Fura 2-AM (Molecular Probes, Eugene, OR) was stored frozen in anhydrous DMSO. Aliquots of reagents were thawed for dilution daily, and excess reagents were discarded at the end of each day.

Statistical analysis. Data in the text and figures are reported as means ± SE. The significance of differences was evaluated with SigmaStat 3.11 (Systat Software, Point Richmond, CA) using parametric or nonparametric tests as appropriate for the data. Comparisons between two groups were performed with Student's t-test (paired or unpaired, as appropriate). Comparisons between multiple groups employed ANOVA or repeated-measures ANOVA. Post hoc comparisons were performed using Tukey's or Holm-Sidak tests. P < 0.05 was used to reject the null hypothesis.


   RESULTS
TOP
 ABSTRACT
 METHODS
 RESULTS
DISCUSSION
 GRANTS
 REFERENCES
 
Modulation of DVR endothelial [Ca2+]CYT by ouabain. We first tested whether inhibition of ouabain-sensitive Na+-K+-ATPase affects basal endothelial [Ca2+]CYT. Baseline DVR endothelial [Ca2+]CYT was typically 50–100 nM (Fig. 1) as previously reported (37, 41, 46). Exposure to incremental concentrations of ouabain between 0.1 nM and 1 µM led to increases in [Ca2+]CYT characterized by a transient peak and sustained plateau. [Ca2+]CYT changes were reversible when ouabain was removed from the bath. The magnitudes of the increases in peak and plateau phases of the response were similar from 10–10 to 10–6 M ouabain (Fig. 1, A and B). Sham exchange of the bath with vehicle did not elicit such responses.


Figure 1
View larger version (24K):
[in this window]
[in a new window]
  		Fig. 1. Descending vasa recta (DVR) endothelial cytosolic Ca2+ concentration ([Ca2+]CYT) changes evoked by ouabain. Vessels were exposed to log molar increasing concentrations of ouabain from 10–10 to 10–6 M (n = 9). At each concentration, ouabain was introduced for 5 min and then removed for 5 min before introduction of the next ouabain concentration. A: representative recording of a single experiment shows background-subtracted fluorescent ratios. B: peak (filled bars) and plateau (open bars, at 5 min) [Ca2+]CYT expressed as % elevations from baseline. C: representative recording from a separate series during exposure to ouabain at 10–6, 10–5, and 10–4 M (n = 7). D: peak (filled bars) and plateau (open bars, at 5 min) [Ca2+]CYT expressed as % elevations from baseline, means ± SE (*P < 0.05). E: areas under the [Ca2+]CYT response curves in the presence of ouabain (5 min, nM x s, data are means ± SE, *P < 0.05).

 
The ouabain affinity of {alpha}2/{alpha}3 isoforms of Na+-K+-ATPase in the rat has been reported to lie near or below 1 nM. In contrast, the more predominant {alpha}1 isoform has a lower affinity, near 100 µM (6, 16, 33). To test whether higher ouabain concentrations that inhibit all Na+-K+-ATPase isoforms have a more pronounced effect on [Ca2+]CYT, a separate series of experiments was performed comparing ouabain at 10–6-10–4 M. As shown in Fig. 1, C-E, a larger [Ca2+]CYT elevation occurred at 10–4 and 10–5 than at 10–6 M (plateau phase; 75.3 ± 8.2 vs. 155.9 ± 24.3 and 149.3 ± 32.9 nM, area under curve; 6,447 ± 1,021 vs. 12,864 ± 1,801 and 12,664 ± 2,603 nM x s, n = 7, P < 0.05). These data suggest that the effect of inhibition of low- and high-affinity Na+-K+-ATPase isoforms on [Ca2+]CYT of DVR endothelia is additive.

Ouabain can depolarize cells by inhibiting the electrogenic exchange of 2K+ for 3Na+ by Na+-K+-ATPase. Thus secondary stimulation of Ca2+ influx via voltage-operated Ca2+ channels (VOCa) might occur into adjacent DVR pericytes upon ouabain application. Myo-endothelial gap junctions are preserved in this preparation and we have shown that DVR pericytes express nifedipine-sensitive VOCa (52). In view of that, we considered that ouabain might elevate endothelial [Ca2+]CYT by increasing the influx of Ca2+ into pericytes followed by secondary transport of Ca2+ to the endothelium via gap junctions. To test that possibility, DVR were pretreated with nifedipine (10–5 M) and then exposed to ouabain (10 nM). Nifedipine did not inhibit ouabain-evoked [Ca2+]CYT transients (Fig. 2A).


Figure 2
View larger version (11K):
[in this window]
[in a new window]
  		Fig. 2. Effect of inhibition of voltage-operated Ca2+ channels (VOCa) on ouabain-evoked DVR endothelial [Ca2+]CYT transients. Ouabain was added 5 min after the introduction of nifedipine (10–5 M) or sham exchange of the bath. A: mean background-subtracted fluorescent ratios are shown as a function of time during ouabain (10 nM) exposure in the presence or absence of nifedipine (10 µM). B: membrane potential of DVR endothelial cells before, during, and after exposure to ouabain (10 nM).

 
It is generally accepted that endothelial cells do not express VOCa (32); however, for completeness, we tested whether nanomolar ouabain depolarizes DVR endothelia. Endothelial membrane potential averaged –53 ± 5 mV at baseline and was not affected by exposure to 10 nM ouabain (Fig. 2B). Thus the depolarization that would be required for putative VOCa activation in endothelium did not occur. From these data, we infer that neither flux of Ca2+ across myoendothelial gap junctions nor voltage-gated Ca2+ entry into endothelial cells could account for ouabain-induced endothelial [Ca2+]CYT transients.

Role of NCX in the ouabain-induced endotheliol calcium transients. We hypothesized that, as in other cell types, ouabain inhibition of the {alpha}2-, {alpha}3-subunit sodium pumps might elevate [Na+] in the vicinity of the NCX thereby reducing clearance of Ca2+ from the endothelium. We first tested whether NCX activity can modulate [Ca2+]CYT of DVR endothelia by lowering extracellular sodium ([Na+]o) or calcium concentration ([Ca2+]o). As shown in Fig. 3, removal of Ca2+ from the bath rapidly reduced [Ca2+]CYT and eliminated ouabain (10–8 M)-induced [Ca2+]CYT transients. Given that other effects such as ER/SR store depletion and alteration of Ca2+ export via Ca2+-ATPase might accompany incubation of cells in 0 Ca2+ bath, we also tested the effect of lowering [Na+]o. Stepwise reduction of [Na+]o elicited incremental elevations of [Ca2+]CYT (Fig. 4), the magnitude of which was similar to that previously observed in aortic myocytes (3). Interestingly, similar to the effects of ouabain, reduction of [Na+]o yielded biphasic [Ca2+]CYT transients with peaks followed by persistent plateau elevations. These data favor a role for participation of NCX in the setting of basal [Ca2+]CYT.


Figure 3
View larger version (10K):
[in this window]
[in a new window]
  		Fig. 3. Effect of removal of Ca2+ from the bath on ouabain-evoked DVR endothelial [Ca2+]CYT transients. Ouabain was introduced or sham exchange was performed 1 min after elimination of Ca2+ from the bath. A: representative recording of a single experiment shows background-subtracted fluorescent ratios. Arrows indicate time points corresponding to comparisons in B. B: bars show [Ca2+]CYT measurements immediately before removal of Ca2+ (0 min in 1 mM Ca2+, arrow 1), 1 min after removal of Ca2+ (1 min in 0 mM Ca2+, arrow 2), and 1 min after ouabain or vehicle exposure (2 min in 0 mM Ca2+, arrow 3). Control, filled bars; ouabain, open bars; n = 4 each. Data are means ± SE.

 

Figure 4
View larger version (17K):
[in this window]
[in a new window]
  		Fig. 4. Effect of lowering of [Na+]o on DVR endothelial [Ca2+]CYT. [Na+]o was sequentially lowered, at 5-min intervals, from 150 to 138, 125, 100, 50, and 0 mM by isosmolar substitution with NMDG+, and finally restored to 150 mM (n = 6), [Na+]o reductions yielded initial "peaks," followed by higher steady-state "plateau" levels of [Ca2+]CYT. 350/380 nm fura-2 fluorescent ratios were obtained at 0.2 Hz by averaging for 2.5 s at each wavelength. Data are means ± SE. Most error bars have been suppressed for clarity.

 
To further establish a role for NCX, we examined baseline [Ca2+]CYT and ouabain-induced [Ca2+]CYT responses during NCX blockade with SEA-0400 (10–6 M), an inhibitor that is respected for its specificity to block NCX1 isoforms (24, 29, 47). Like reduction of [Na+]o, pharmacological inhibition of NCX increased baseline [Ca2+]CYT (control, 71.7 ± 5.1 nM, vs. SEA-0400, 179 ± 40.9 nM, n = 6 each, after 5 min at arrow 1, Fig. 5A). Furthermore, 5-min pretreatment with SEA-0400 almost completely abolished ouabain-induced [Ca2+]CYT elevations (control; from 72 ± 5.1 to 424 ± 69.8 nM, vs. SEA-0400; from 179 ± 40.9 to 215 ± 28.2 nM, P < 0.05, at arrow 2, Fig. 5B).


Figure 5
View larger version (12K):
[in this window]
[in a new window]
  		Fig. 5. Effect of SEA-0400 pretreatment on ouabain-induced [Ca2+]CYT transients in DVR endothelium. A: SEA-0400 or vehicle was added to the bath 5 min before introduction of ouabain. Na+/Ca2+ exchanger (NCX) inhibition with SEA-0400 elevated baseline [Ca2+]CYT. Ouabain exposure was continued for 5 min. [Ca2+]CYT responses to ouabain following SEA-0400 pretreatment were suppressed. B: peak [Ca2+]CYT changes induced by ouabain are compared. Data are means ± SE, *P < 0.05.

 
2-APB and cation channel blockade inhibits ouabain-evoked calcium transients. Hypothetically, inhibition of NCX could explain the ability of ouabain to elevate [Ca2+]CYT without invoking a need for participation of other Ca2+ transport pathways. The biphasic "peak and plateau" [Ca2+]CYT responses shown in Figs. 1–5, however, raise the question of release of Ca2+ from internal stores and influx of Ca2+ from the extracellular space via store-operated nonselective cation channels. Given that ouabain enhances storage of Ca2+ in some cells (18) and has recently been shown to signal through PLC and InsP3 in renal epithelial (LLC-PK1) cells (50, 51), we tested other pathways. A selective blocker of InsP3R-mediated Ca2+ release from stores does not exist; however, 2-APB (5 x 10–5 M) blocks InsP3R along with store-operated Ca2+ channels (10, 11). As shown in Fig. 6, 2-APB decreased baseline endothelial [Ca2+]CYT (control; 106 ± 13.9, n = 7 vs. 2-APB; 62.4 ± 7.5 nM, n = 8). Exposure to ouabain in the presence of 2-APB led to a subdued [Ca2+]CYT response with a minimal, transient elevation (compare Figs. 1 and 6; control; from 106 ± 13.9 to 285 ± 28.3, vs. 2-APB; from 62.4 ± 7.5 to 86.7 ± 9.3 nM).


Figure 6
View larger version (14K):
[in this window]
[in a new window]
  		Fig. 6. Effect of 2-aminoethoxydiphenyl borate (2-APB) on ouabain-induced [Ca2+]CYT transients. Fura-2-loaded DVR were pretreated with 2-APB (5 x 10–5 M) or vehicle before ouabain exposure. Baseline [Ca2+]CYT was lower in 2-APB and ouabain-evoked peak [Ca2+]CYT elevations were suppressed. Data are means ± SE.

 
If InsP3 generation occurs in DVR endothelia exposed to ouabain, secondary activation of Ca2+ influx via nonselective cation channels might also result from cellular store depletion. We tested for participation of such pathways by examining ouabain responses in the presence of SKF-96365 (10 µM) and La3+ (10 µM), agents that are known to block mechanosensitive [Ca2+]CYT transients in these cells (53). La3+ ion, at a concentration of 10 µM, spares inhibition of NCX and Ca2+ extrusion pumps (9, 44). As shown in Fig. 7, both agents attenuated the [Ca2+]CYT response to ouabain.


Figure 7
View larger version (9K):
[in this window]
[in a new window]
  		Fig. 7. Effect of cation channel blockade on ouabain-induced [Ca2+]CYT transients. Fura-2-loaded DVR endothelia were exposed to ouabain (10 nM) in the presence of nonselective cation channel blockade with SKF-96365 (10 µM; A) or La3+ (10 µM; B). Both agents attenuated the [Ca2+]CYT response to ouabain (compare with Figs. 1, 5, 6).

 
As with the response to ouabain (Fig. 1), transient peak [Ca2+]CYT elevation accompanies inhibition of NCX through [Na+]o reduction (Fig. 4). It has been hypothesized that localized [Ca2+]CYT elevations near NCX might stimulate store Ca2+ release through stimulation of PLC generation of InsP3 or by direct actions on InsP3R (Ca2+-induced Ca2+ release). In view of this, we tested the ability of 2-APB to block the [Ca2+]CYT response to [Na+]o reduction. The protocol used in Fig. 4 was repeated, but with 2-APB present in the bath (Fig. 8). As in Fig. 6, 2-APB lowered baseline [Ca2+]CYT. The transients (arrows, Fig. 8) associated with putative store release were suppressed (control, n = 6 vs. 2-APB, n = 8; 150 mM [Na+]o: 61.7 ± 9.5 vs. 41.5 ± 4.2, 138 mM: 118 ± 15.3 vs. 85.2 ± 13.3, 125 mM: 160 ± 22.6 vs. 124 ± 19.2, 100 mM: 250 ± 36.7 vs. 208 ± 36.0, 50 mM: 342 ± 41.5 vs. 331 ± 47, 0 mM: 380 ± 37.0 vs. 381 ± 83.8 nM). Attenuation of the [Ca2+]CYT response by 2-APB implies participation of Ca2+ release or entry pathways but the persistence of the stepwise increase in plateau [Ca2+]CYT in 2-APB suggests that it does not inhibit NCX.


Figure 8
View larger version (12K):
[in this window]
[in a new window]
  		Fig. 8. Effect of 2-APB and La3+ on DVR endothelial [Ca2+]CYT response to [Na+]o reduction. A: protocol illustrated in Fig. 4 was repeated in the presence of 2-APB (5 x 10–5 M). [Na+]o reduction induced a progressive elevation of [Ca2+]CYT in the presence or absence of 2-APB. Baseline [Ca2+]CYT was lower in 2-APB than vehicle and [Ca2+]CYT peaks, indicated by arrows, were diminished. B: example of an experiment in which the ability of nonselective cation channel blockade with La3+ (10 µM) to prevent [Ca2+]CYT responses to [Na+]o reduction was tested. C: summary of n = 7 experiments similar to B. bullet, Individual experiments. {circ}, Means ± SE.

 
Nonselective cation channels conduct both Na+ and Ca2+ into the cytoplasm. Reduction of extracellular Na+ might affect Ca2+ entry, independent of NCX, by reducing competition between those cations for ion channel selectivity filter(s) (35, 39). Alternately, cation channels might be activated during [Na+]o reduction through NCX inhibition that leads to Ca2+-induced Ca2+ release (CICR) and store depletion. To test those possibilities, we performed experiments in which [Na+]o was reduced from 150 to 125 mM in the presence of La3+ (10 µM). DVR endothelial [Ca2+]CYT increased from 45 ± 9 to 221 ± 34 nM (Fig. 8, B and C) showing that block of La3+-sensitive cation channels does not have significant effect on the response (compare with Fig. 8A).

Ouabain enhancement of BK-evoked endothelial calcium transients. It has been proposed that ouabain-induced inhibition of Ca2+ export leads to ER/SR store loading that favors enhancement of [Ca2+]CYT release by agonists (1, 2, 7). BK induces large peak-phase DVR endothelial [Ca2+]CYT transients attributable to ER/SR store release (37, 46). We therefore tested whether [Ca2+]CYT responses to BK are enhanced by ouabain. BK (10–7 M)-evoked [Ca2+]CYT elevation was augmented by prolonged (10 min) pretreatment with ouabain at a concentration (5 x 10–5 M) that should affect all Na+-K+-ATPase isoforms (Fig. 9, A and B, area under the curve, 40,001 ± 8,765, n = 7 vs. 100,159 ± 21,263 nM x s, n = 7, P < 0.05). Basal [Ca2+]CYT was higher during ouabain exposure. When DVR were pretreated with ouabain at low concentration (10–8 M) selective for {alpha}2/{alpha}3 Na+-K+-ATPase, similar augmentation of the response to BK was observed (26,336 ± 3,883, n = 7 vs. 44,808 ± 8,360 nM x s, n = 7, P < 0.05, Fig. 9, C and D).


Figure 9
View larger version (20K):
[in this window]
[in a new window]
  		Fig. 9. Effect of ouabain on DVR endothelial [Ca2+]CYT elevation evoked by bradykinin (BK). A: DVR were exposed to BK for 5 min to elicit a baseline response. Subsquently, vehicle (n = 6) or ouabain (500 nM, n = 9) was introduced into the bath for 5 min and vessels were exposed to BK a second time. Vessels exposed to ouabain had significant elevation of [Ca2+]CYT (*P < 0.05). The second BK-induced [Ca2+]CYT response was higher after ouabain (*P < 0.05). B: summary of area under the curve comparisons of [Ca2+]CYT during the first and second exposures to BK (mean ± SE, *P < 0.05). Ouabain enhanced the peak phase BK-induced [Ca2+]CYT response. C: DVR were preexposed to ouabain (10 nM) or vehicle for 10 min followed by 10-min BK stimulation (10–7 M). D: area under the curve comparison for the first 5 min of BK exposure in C. At lower concentration, ouabain (10 nM) also enhanced the peak phase [Ca2+]CYT response. Data are means ± SE.

 

   DISCUSSION
TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
GRANTS
 REFERENCES
 
Four isoforms of the Na+-K+-ATPase catalytic subunit ({alpha}1-{alpha}4) are expressed in mammalian cells. The {alpha}1 catalytic subunit with low ouabain affinity is the dominant isoform that maintains transcellular Na+ and K+ concentration gradients and mediates salt reabsorption in the kidney. Circulating OLF is present in concentrations that are too low to affect the {alpha}1-isoform in rodents. One hypothesis proposes that the effect of ouabain to modulate [Ca2+]CYT signaling results from its inhibition of high-affinity {alpha}2-, {alpha}3-, or {alpha}4-isoforms (22, 30). Reduction of Na+ export then leads to an increase in localized [Na+]CYT (in the vicinity of NCX) that reduces or reverses the direction of NCX favoring reduction of Ca2+ export and augmentation of cellular ER/SR Ca2+ store loading (7, 8, 26). NCX and {alpha}2/{alpha}3-isoforms may be localized to discrete functional units within cells. Recent investigations in astrocytes and mesenteric arteriolar myocytes found the ouabain-sensitive {alpha}2/{alpha}3-isoforms and NCX in specialized "junctional" regions that coincide with ER/SR (6, 8, 16, 18, 25). Similar colocalization of {alpha}2/{alpha}3 and NCX in DVR endothelium is unexplored; however, the ability of [Na+]o reduction to increase [Ca2+]CYT in DVR endothelia (Fig. 4) favors a role for NCX in the setting of basal [Ca2+]CYT and reproduces the findings of others (27). A role for NCX is also favored by the ability of SEA-0400 to increase basal [Ca2+]CYT (Fig. 5). SEA-0400 is a potent blocker of predominant NCX1 isoforms and is generally respected for its specificity to block NCX without affecting cytoplasmic Ca2+ extrusion pumps (24, 29, 47). Nonetheless, some interpretational caution is in order because SEA-0400 has been shown to alter [Ca2+]CYT signaling in cells that lack NCX (40).

Ouabain elicits calcium transients in the DVR endothelium. Using fura 2-loaded DVR, we found that ouabain, at 0.1 nM-0.1 mM, affects basal DVR endothelial [Ca2+]CYT (Fig. 1). The lower end of that concentration range is similar to that of OLF in plasma (20) and is sufficient to affect {alpha}2/{alpha}3 Na+-K+-ATPase in the rat. Several findings in Fig. 1 are of interest. First, ouabain modulates basal [Ca2+]CYT in this microvascular endothelium, an effect that is not uniformly present in all preparations (27, 28, 49). Because these studies were performed with fura-2, a probe that distributes diffusely into the cytoplasm, we conclude that ouabain-induced [Ca2+]CYT elevation occurs globally throughout the cells. It is possible that much greater effects on [Ca2+]CYT occur in the "junctional region" near the plasma membrane and NCX. Such a compartmental effect would not be delineated by fura 2 for two reasons. First, the affinity of fura 2 for Ca2+ is low; i.e., near-membrane Ca2+ binding to fura 2 might be saturated if junctional Ca2+ ([Ca2+]JNT) concentrations are very high. Second, fura 2 fluorescence from the bulk cytoplasm probably overwhelms any emanations from the junctional cytoplasm. A second, interesting feature of the response in Fig. 1 is that ouabain gives a biphasic [Ca2+]CYT change comprised of an early peak followed by a sustained plateau. Observation times in Fig. 1 were brief; however, plateau [Ca2+]CYT elevations are sustained for at least 10 min (data not shown). Finally, the response to ouabain is remarkably similar over a broad range of concentrations from 0.1 nM to 1 µM (Fig. 1, A and B). When ouabain concentration is increased further, a greater elevation of [Ca2+]CYT is observed (Fig. 1, C-E). We interpret those findings as evidence that both high-ouabain affinity ({alpha}2/{alpha}3) and low-affinity ({alpha}1) Na+ pump isoforms participate in the modulation of [Ca2+]CYT.

The biphasic pattern of [Ca2+]CYT in Fig. 1 is atypical of pure NCX inhibition. That observation stimulated us to examine whether other pathways participate in acute ouabain [Ca2+]CYT elevation. Much work by Xie and colleagues (40, 50) highlighted the ability of ouabain binding to Na+ pumps to trigger multiple signaling cascades that occur along with NCX inhibition. Of particular interest in the current context is that ouabain may stimulate phosphorylation of PLC{gamma} leading to InsP3 generation and biphasic [Ca2+]CYT signaling in LLC-PK1 cells (51). Cross talk between these signaling pathways has been proposed. NCX inhibition by Na+ elevation in the junctional region between plasmalemma and ER/SR ([Na+]JNT) might enhance InsP3-mediated signaling if resultant junctional [Ca2+]JNT elevation provides positive feedback to further stimulate PLC (23). [Ca2+]JNT elevation might also induce CICR through InsP3R stimulation (Fig. 10). Our observations support the participation of multiple pathways in ouabain signaling. SEA-0400 prevented ouabain responses, implicating an important role for NCX1 isoforms (Fig. 5). A role for InsP3R stimulation is favored by the successful blockade of ouabain responses with 2-APB (Fig. 6). Finally, the ability of low [Ca2+]o (Fig. 3) as well as cation channel blockade with La3+ and SKF-96365 (Fig. 7) to attenuate ouabain responses points to a possible role for modulation of Ca2+ entry.


Figure 10
View larger version (17K):
[in this window]
[in a new window]
  		Fig. 10. Mechanisms of ouabain-induced [Ca2+]CYT signaling in DVR endothelium. Possible scheme involving participation of NCX, inositol tris-phosphate receptor (InsP3R), and cation channels in DVR endothelial ouabain signaling. Nanomolar ouabain selectively inhibits those Na+-K+-ATPase comprised of {alpha}2-catalytic subunits. That inhibition raises [Na+]JNT in the vicinity of NCX of cytoplasmic "junctional" microdomains that overlie endoplasmic/sarcoplasmic reticulum (ER/SR) Ca2+ stores (2, 6). Inhibition of Ca2+ export by NCX leads to increase in junctional [Ca2+]JNT favoring enhanced uptake into ER/SR stores via Ca2+ pumps. The greater load of Ca2+ in ER/SR stores favors higher "bulk" [Ca2+]CYT and greater agonist-induced Ca2+ release via InsP3R. Parallel signaling processes occur through stimulation of PLC, which may be phosphorylated (Y-p) (51) and stimulated by the increase in [Ca2+]JNT (23). InsP3 generated by PLC combined with the increase in [Ca2+]JNT due to NCX inhibition stimulates further Ca2+ release by InsP3R leading to secondary opening of store-operated nonselective cation channels that transport Na+ and Ca2+ ions.

 
NCX modulates DVR endothelial [Ca2+]CYT. Participation of NCX in the setting of basal [Ca2+]CYT of DVR endothelia has not been previously explored. In this study, a role for NCX was supported by two experiments. First, a progressive rise of endothelial [Ca2+]CYT occurs in response to step decreases of [Na+]o, even when the [Na+]o reduction is small (Fig. 4). Second, NCX blockade with SEA-0400 raises [Ca2+]CYT (Fig. 5). In one study, conducted in aortic endothelial cells, lowering [Na+]o caused a transient [Ca2+]CYT elevation that did not persist (49). In other studies, progressive [Ca2+]CYT elevation was observed during [Na+]o reduction that mirrors our results (14, 26, 27). Such variation may reflect regional differences in the role of NCX at sites along the vasculature. Taken together, we propose that NCX may participate, along with plasmalemmal ATP-dependent Ca2+ extrusion pumps, to maintain DVR endothelial [Ca2+]CYT at low levels in the basal state.

Ouabain potentiates BK-induced calcium transients. In addition to inhibition of NCX, elevations of [Ca2+]CYT by ouabain probably involve release of Ca2+ from cellular stores. The tendency of ouabain and NCX inhibition (low [Na+]o or SEA-0400) to yield nonsustained "peak" [Ca2+]CYT transients hints at that possibility (Figs. 1, 4, 5A). The finding that 2-APB prevents both ouabain-induced [Ca2+]CYT transients (Fig. 6) and NCX-mediated transients (Fig. 8) is also supportive. Unfortunately, a perfect blocker of ER/SR store release via InsP3R does not exist. Heparin, xestospongin C, and 2-APB are commonly used to block InsP3R but neither is perfectly selective (10, 11). 2-APB, used in the present study, has dual actions to inhibit InsP3R and block Ca2+ entry from the extracellular space through store-operated cation channels. Participation of Ca2+ entry in the ouabain response is supported by the finding that La3+ and SKF-96365 attenuate it. Given the imperfect specificity of 2-APB, we recognize that evidence for participation of InsP3R participation in the ouabain response is incomplete. Nonetheless, the clear demonstration by Yuan and colleagues (51) that InsP3 generation can be stimulated through ouabain binding to Na+ pump {alpha}-subunits reinforces the possibility.

To further examine the role of cellular Ca2+ stores in ouabain responses, we tested its effects on BK signaling. BK is an agonist that releases Ca2+ from the ER/SR by InsP3R-dependent signaling (4) and is an optimal agonist in the current context because it consistently generates rapid and large transient elevations of DVR endothelial [Ca2+]CYT (37, 41, 46). Augmentation of the peak phase of store release by ouabain was readily demonstrated at both high and low ouabain concentrations (Fig. 8). That observation parallels the recent finding that ouabain enhances [Ca2+]CYT transients in BK-stimulated rat aortic endothelial cells (14). A similar ability of ouabain to enhance [Ca2+]CYT transients in smooth muscle has also been described (1, 2).

A hypothesis that accounts for the effects of ouabain in DVR endothelium must explain its modulation of global [Ca2+]CYT (as measured by fura-2) and its dependence on NCX, cation channels, and InsP3R activity. A possible scheme is illustrated in Fig. 10. It has been proposed that ouabain-induced subplasmalemmal [Ca2+]JNT elevation, resulting from reduction of NCX Ca2+ export, enhances Ca2+ loading into ER/SR stores via SERCA pumps (17). In support of this, a steep dependence of agonist-induced, InsP3-mediated Ca2+ release on the Ca2+ load of the stores has been reported in myocytes (45). Another mechanism, possibly contributing to ouabain-induced global [Ca2+]CYT elevations, is CICR. It is known that Ca2+ elevations associated with the reverse mode operation of NCX evoke CICR that amplifies [Ca2+]CYT responses in cardiac myocytes (4, 5, 48). In pancreatic beta-cells, CICR induced by SERCA pump inhibition was found to be dependent on InsP3R (15). CICR is less well explored in endothelia but does exist (13, 31, 34). Comparison of the effect of low [Na+]o on [Ca2+]CYT in the presence or absence of 2-APB (Fig. 8) reveals that step decreases in [Na+]o evoke [Ca2+]CYT transients. These may be triggered by NCX inhibition through the CICR mechanism. In addition to possible InsP3 generation (51), the same mechanism might partially account for the observed transient peaks of [Ca2+]CYT elicited by ouabain (Fig. 1). Based on these observations, we conclude that circulating OLF might affect DVR endothelial Ca2+ signaling through actions on NCX and InsP3R. Within the renal medulla, the potential for ouabain to modulate release of vasodilators by DVR endothelia can be inferred. Given that vasoactivity and NO release in the renal medulla affect Na+ balance and blood pressure (12), the current observations may point to an important role for circulating OLF in renal function.


   GRANTS
TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
REFERENCES
 
This work was supported by National Institutes of Health Grants DK-42495, DK-68492, DK-67621, and HL-78870.


   FOOTNOTES
 

Address for reprint requests and other correspondence: T. L. Pallone, Division of Nephrology, UMMS, 22 S. Greene St, N3W143, Univ. of Maryland at Baltimore, Baltimore, MD 21201-1595 (e-mail: tpallone{at}medicine.umaryland.edu)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


   REFERENCES
TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. Arnon A, Hamlyn JM, and Blaustein MP. Na+ entry via store-operated channels modulates Ca2+ signaling in arterial myocytes. Am J Physiol Cell Physiol 278: C163–C173, 2000.[Abstract/Free Full Text]
  2. Arnon A, Hamlyn JM, and Blaustein MP. Ouabain augments Ca2+ transients in arterial smooth muscle without raising cytosolic Na+. Am J Physiol Heart Circ Physiol 279: H679–H691, 2000.[Abstract/Free Full Text]
  3. Batlle DC, Godinich M, LaPointe MS, Munoz E, Carone F, and Mehring N. Extracellular Na+ dependency of free cytosolic Ca2+ regulation in aortic vascular smooth muscle cells. Am J Physiol Cell Physiol 261: C845–C856, 1991.[Abstract/Free Full Text]
  4. Berridge MJ, Lipp P, and Bootman MD. The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 1: 11–21, 2000.[CrossRef][Web of Science][Medline]
  5. Bers DM. Cardiac excitation-contraction coupling. Nature 415: 198–205, 2002.[CrossRef][Medline]
  6. Blaustein MP and Golovina VA. Structural complexity and functional diversity of endoplasmic reticulum Ca2+ stores. Trends Neurosci 24: 602–608, 2001.[CrossRef][Web of Science][Medline]
  7. Blaustein MP, Juhaszova M, and Golovina VA. The cellular mechanism of action of cardiotonic steroids: a new hypothesis. Clin Exp Hypertens 20: 691–703, 1998.[CrossRef][Web of Science][Medline]
  8. Blaustein MP, Juhaszova M, Golovina VA, Church PJ, and Stanley EF. Na/Ca exchanger and PMCA localization in neurons and astrocytes: functional implications. Ann NY Acad Sci 976: 356–366, 2002.[Web of Science][Medline]
  9. Blaustein MP and Lederer WJ. Sodium/calcium exchange: its physiological implications. Physiol Rev 79: 763–854, 1999.[Abstract/Free Full Text]
  10. Bootman MD, Collins TJ, Mackenzie L, Roderick HL, Berridge MJ, and Peppiatt CM. 2-Aminoethoxydiphenyl borate (2-APB) is a reliable blocker of store-operated Ca2+ entry but an inconsistent inhibitor of InsP3-induced Ca2+ release. FASEB J 16: 1145–1150, 2002.[Abstract/Free Full Text]
  11. Castonguay A and Robitaille R. Xestospongin C is a potent inhibitor of SERCA at a vertebrate synapse. Cell Calcium 32: 39–47, 2002.[CrossRef][Web of Science][Medline]
  12. Cowley AW Jr, Mori T, Mattson D, and Zou AP. Role of renal NO production in the regulation of medullary blood flow. Am J Physiol Regul Integr Comp Physiol 284: R1355–R1369, 2003.[Abstract/Free Full Text]
  13. Domenighetti AA, Beny JL, Chabaud F, and Frieden M. An intercellular regenerative calcium wave in porcine coronary artery endothelial cells in primary culture. J Physiol 513: 103–116, 1998.[Abstract/Free Full Text]
  14. Dong XH, Komiyama Y, Nishimura N, Masuda M, and Takahashi H. Nanomolar level of ouabain increases intracellular calcium to produce nitric oxide in rat aortic endothelial cells. Clin Exp Pharmacol Physiol 31: 276–283, 2004.[CrossRef][Web of Science][Medline]
  15. Dyachok O, Tufveson G, and Gylfe E. Ca2+-induced Ca2+ release by activation of inositol 1,4,5-trisphosphate receptors in primary pancreatic beta-cells. Cell Calcium 36: 1–9, 2004.[CrossRef][Web of Science][Medline]
  16. Golovina V, Song H, James P, Lingrel J, and Blaustein M. Regulation of Ca2+ signaling by Na+ pump alpha-2 subunit expression. Ann NY Acad Sci 986: 509–513, 2003.[CrossRef][Web of Science][Medline]
  17. Golovina VA and Blaustein MP. Unloading and refilling of two classes of spatially resolved endoplasmic reticulum Ca2+ stores in astrocytes. Glia 31: 15–28, 2000.[CrossRef][Web of Science][Medline]
  18. Golovina VA, Song H, James PF, Lingrel JB, and Blaustein MP. Na+ pump {alpha}2-subunit expression modulates Ca2+ signaling. Am J Physiol Cell Physiol 284: C475–C486, 2003.[Abstract/Free Full Text]
  19. Hamlyn JM. Biosynthesis of endogenous cardiac glycosides by mammalian adrenocortical cells: three steps forward. Clin Chem 50: 469–470, 2004.[Free Full Text]
  20. Hamlyn JM, Blaustein MP, Bova S, DuCharme DW, Harris DW, Mandel F, Mathews WR, and Ludens JH. Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acad Sci USA 88: 6259–6263, 1991.[Abstract/Free Full Text]
  21. Hamlyn JM, Lu ZR, Manunta P, Ludens JH, Kimura K, Shah JR, Laredo J, Hamilton JP, Hamilton MJ, and Hamilton BP. Observations on the nature, biosynthesis, secretion and significance of endogenous ouabain. Clin Exp Hypertens 20: 523–533, 1998.[CrossRef][Web of Science][Medline]
  22. Hansen O. No evidence for a role in signal transduction of Na+-K+-ATPase interaction with putative endogenous ouabain. Eur J Biochem 270: 1916–1919, 2003.[Web of Science][Medline]
  23. Horowitz LF, Hirdes W, Suh BC, Hilgemann DW, Mackie K, and Hille B. Phospholipase C in living cells: activation, inhibition, Ca2+ requirement, and regulation of M current. J Gen Physiol 126: 243–262, 2005.[Abstract/Free Full Text]
  24. Iwamoto T. Forefront of Na+/Ca2+ exchanger studies: molecular pharmacology of Na+/Ca2+ exchange inhibitors. J Pharm Sci 96: 27–32, 2004.
  25. Juhaszova M and Blaustein MP. Na+ pump low and high ouabain affinity alpha subunit isoforms are differently distributed in cells. Proc Natl Acad Sci USA 94: 1800–1805, 1997.[Abstract/Free Full Text]
  26. Kaye DM and Kelly RA. Expression and regulation of the sodium-calcium exchanger in cardiac microvascular endothelial cells. Clin Exp Pharmacol Physiol 26: 651–655, 1999.[CrossRef][Web of Science][Medline]
  27. Li L and van Breemen C. Na+-Ca2+ exchange in intact endothelium of rabbit cardiac valve. Circ Res 76: 396–404, 1995.[Abstract/Free Full Text]
  28. Liang W, Buluc M, van Breemen C, and Wang X. Vectorial Ca2+ release via ryanodine receptors contributes to Ca2+ extrusion from freshly isolated rabbit aortic endothelial cells. Cell Calcium 36: 431–443, 2004.[CrossRef][Web of Science][Medline]
  29. Matsuda T, Arakawa N, Takuma K, Kishida Y, Kawasaki Y, Sakaue M, Takahashi K, Takahashi T, Suzuki T, Ota T, Hamano-Takahashi A, Onishi M, Tanaka Y, Kameo K, and Baba A. SEA0400, a novel and selective inhibitor of the Na+-Ca2+ exchanger, attenuates reperfusion injury in the in vitro and in vivo cerebral ischemic models. J Pharmacol Exp Ther 298: 249–256, 2001.[Abstract/Free Full Text]
  30. Mobasheri A, Errington RJ, Golding S, Hall AC, and Urban JP. Characterization of the Na+-K+-ATPase in isolated bovine articular chondrocytes; molecular evidence for multiple alpha and beta isoforms. Cell Biol Int 21: 201–212, 1997.[CrossRef][Web of Science][Medline]
  31. Mozhayeva MG and Mozhayeva GN. Evidence for the existence of inositol (1,4,5)-trisphosphate- and ryanodine-sensitive pools in bovine endothelial cells. Ca2+ releases in cells with different basal level of intracellular Ca2+. Pflügers Arch 432: 614–622, 1996.[CrossRef][Web of Science][Medline]
  32. Nilius B and Droogmans G. Ion channels and their functional role in vascular endothelium. Physiol Rev 81: 1415–1459, 2001.[Abstract/Free Full Text]
  33. O'Brien WJ, Lingrel JB, and Wallick ET. Ouabain binding kinetics of the rat alpha two and alpha three isoforms of the sodium-potassium adenosine triphosphate. Arch Biochem Biophys 310: 32–39, 1994.[CrossRef][Web of Science][Medline]
  34. Otun H, Aidulis DM, Yang JM, and Gillespie JI. Interactions between inositol trisphosphate and Ca2+ dependent Ca2+ release mechanisms on the endoplasmic reticulum of permeabilised bovine aortic endothelial cells. Cell Calcium 19: 315–325, 1996.[CrossRef][Web of Science][Medline]
  35. Owsianik G, Talavera K, Voets T, and Nilius B. Permeation and selectivity of trp channels. Annu Rev Physiol 68: 685–717, 2006.[CrossRef][Web of Science][Medline]
  36. Pallone TL and Silldorff EP. Pericyte regulation of renal medullary blood flow. Exp Nephrol 9: 165–170, 2001.[CrossRef][Web of Science][Medline]
  37. Pallone TL, Silldorff EP, and Cheung JY. Response of isolated rat descending vasa recta to bradykinin. Am J Physiol Heart Circ Physiol 274: H752–H759, 1998.[Abstract/Free Full Text]
  38. Pallone TL, Zhang Z, and Rhinehart K. Physiology of the renal medullary microcirculation. Am J Physiol Renal Physiol 284: F253–F266, 2003.[Abstract/Free Full Text]
  39. Pedersen SF, Owsianik G, and Nilius B. TRP channels: an overview. Cell Calcium 38: 233–252, 2005.[CrossRef][Web of Science][Medline]
  40. Reuter H, Henderson SA, Han T, Matsuda T, Baba A, Ross RS, Goldhaber JI, and Philipson KD. Knockout mice for pharmacological screening: testing the specificity of Na+-Ca2+ exchange inhibitors. Circ Res 91: 90–92, 2002.[Abstract/Free Full Text]
  41. Rhinehart K, Handelsman CA, Silldorff EP, and Pallone TL. ANG II AT2 receptor modulates AT1 receptor-mediated descending vasa recta endothelial Ca2+ signaling. Am J Physiol Heart Circ Physiol 284: H779–H789, 2003.[Abstract/Free Full Text]
  42. Rhinehart K, Zhang Z, and Pallone TL. Ca2+ signaling and membrane potential in descending vasa recta pericytes and endothelia. Am J Physiol Renal Physiol 283: F852–F860, 2002.[Abstract/Free Full Text]
  43. Rhinehart KL and Pallone TL. Nitric oxide generation by isolated descending vasa recta. Am J Physiol Heart Circ Physiol 281: H316–H324, 2001.[Abstract/Free Full Text]
  44. Shimizu H, Borin ML, and Blaustein MP. Use of La3+ to distinguish activity of the plasmalemmal Ca2+ pump from Na+/Ca2+ exchange in arterial myocytes. Cell Calcium 21: 31–41, 1997.[CrossRef][Web of Science][Medline]
  45. Shmygol A and Wray S. Modulation of agonist-induced Ca2+ release by SR Ca2+ load: direct SR and cytosolic Ca2+ measurements in rat uterine myocytes. Cell Calcium 37: 215–223, 2005.[CrossRef][Web of Science][Medline]
  46. Silldorff EP and Pallone TL. Adenosine signaling in outer medullary descending vasa recta. Am J Physiol Regul Integr Comp Physiol 280: R854–R861, 2001.[Abstract/Free Full Text]
  47. Tanaka H, Nishimaru K, Aikawa T, Hirayama W, Tanaka Y, and Shigenobu K. Effect of SEA0400, a novel inhibitor of sodium-calcium exchanger, on myocardial ionic currents. Br J Pharmacol 135: 1096–1100, 2002.[CrossRef][Web of Science][Medline]
  48. Viatchenko-Karpinski S and Gyorke S. Modulation of the Ca2+-induced Ca2+ release cascade by beta-adrenergic stimulation in rat ventricular myocytes. J Physiol 533: 837–848, 2001.[Abstract/Free Full Text]
  49. Wang X, Reznick S, Li P, Liang W, and van Breemen C. Ca2+ removal mechanisms in freshly isolated rabbit aortic endothelial cells. Cell Calcium 31: 265–277, 2002.[CrossRef][Web of Science][Medline]
  50. Xie Z and Cai T. Na+-K+-ATPase-mediated signal transduction: from protein interaction to cellular function. Mol Interv 3: 157–168, 2003.[Abstract/Free Full Text]
  51. Yuan Z, Cai T, Tian J, Ivanov AV, Giovannucci DR, and Xie Z. Na-K-ATPase tethers phospholipase C and IP3 receptor into a calcium-regulatory complex. Mol Biol Cell 16: 4034–4045, 2005.[Abstract/Free Full Text]
  52. Zhang Z, Cao C, Lee-Kwon W, and Pallone TL. Descending vasa recta pericytes express voltage operated Na+ conductance in the rat. J Physiol 567: 445–457, 2005.[Abstract/Free Full Text]
  53. Zhang Z and Pallone TL. Response of descending vasa recta to luminal pressure. Am J Physiol Renal Physiol 287: F535–F542, 2004.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 Am. J. Physiol. Renal Physiol.Home page
C. Cao, K. Payne, W. Lee-Kwon, Z. Zhang, S. W. Lim, J. Hamlyn, M. P. Blaustein, H. M. Kwon, and T. L. Pallone
Chronic ouabain treatment induces vasa recta endothelial dysfunction in the rat
Am J Physiol Renal Physiol, January 1, 2009; 296(1): F98 - F106.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
Q. Zhang, C. Cao, Z. Zhang, W. G. Wier, A. Edwards, and T. L. Pallone
Membrane current oscillations in descending vasa recta pericytes
Am J Physiol Renal Physiol, March 1, 2008; 294(3): F656 - F666.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
L. C. Ng, B. D. Kyle, A. R. Lennox, X.-M. Shen, W. J. Hatton, and J. R. Hume
Cell culture alters Ca2+ entry pathways activated by store-depletion or hypoxia in canine pulmonary arterial smooth muscle cells
Am J Physiol Cell Physiol, January 1, 2008; 294(1): C313 - C323.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
A. Edwards and T. L. Pallone
Ouabain modulation of cellular calcium stores and signaling
Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1518 - F1532.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
H. K. Saini and N. S. Dhalla
Sarcolemmal cation channels and exchangers modify the increase in intracellular calcium in cardiomyocytes on inhibiting Na+-K+-ATPase
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H169 - H181.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
A. Edwards and T. L. Pallone
Modification of cytosolic calcium signaling by subplasmalemmal microdomains
Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1827 - F1845.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/4/F761    most recent
00326.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pittner, J.
Right arrow Articles by Pallone, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pittner, J.
Right arrow Articles by Pallone, T. L.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.